February 13, 2020 / 10:52 PM / 5 days ago

BRIEF-Atreca Announces First Patient Dosed In Phase 1B Clinical Trial Of ATRC-101

Feb 13 (Reuters) - Atreca Inc:

* ATRECA ANNOUNCES FIRST PATIENT DOSED IN PHASE 1B CLINICAL TRIAL OF ATRC-101 IN PATIENTS WITH SELECT SOLID TUMORS

* ATRECA INC - TRIAL WILL ALSO EVALUATE POTENTIAL BIOMARKERS AND INITIAL SIGNALS OF CLINICAL ACTIVITY OF ATRC-101 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below